Advertisement

Reactions Weekly

, Volume 1730, Issue 1, pp 21–21 | Cite as

Alemtuzumab

Various toxicities: 6 case reports
Case report
  • 16 Downloads

Reference

  1. Thota S, et al. Therapeutic outcomes using subcutaneous low dose alemtuzumab for acquired bone marrow failure conditions. British Journal of Haematology 183: 133-136, No. 1, Oct 2018. Available from: URL: http://doi.org/10.1111/bjh.14907 - USA

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations